期 |
栏目 |
标题 |
文件 |
卷 78, 编号 9 (2003) |
Editorial |
Long-term results of structum® administration (data from a multicenter trial) |
|
卷 79, 编号 5 (2004) |
Editorial |
Pulmonary hypertension in patients with systemic sclerosis with CREST-syndrome and without it |
|
卷 79, 编号 1 (2004) |
Editorial |
Role of inflammatory and infectious factors in the development of atherosclerosis |
|
卷 79, 编号 3 (2004) |
Editorial |
Glucocorticosteroids in the treatment of exacerbation of bronchial asthma |
|
卷 79, 编号 5 (2004) |
Editorial |
Grounds for development of endothelial dysfunction in rheumatoid arthritis |
|
卷 79, 编号 12 (2004) |
Editorial |
Vasoregulating activity of the endothelium and pulmonary hypertension |
|
卷 80, 编号 12 (2008) |
Editorial |
Endothelial dysfunction in osteoarthrosis patients: changes in response to teraflex treatment |
|
卷 81, 编号 3 (2009) |
Editorial |
Arterial stiffness and risk factors of cardiovascular disease |
|
卷 81, 编号 6 (2009) |
Editorial |
Cardiovascular risk in patients with rheumatoid arthritis |
|
卷 81, 编号 6 (2009) |
Editorial |
Heart rate variability in patients with ankylosing spondilitis (Bekhterev's disease) |
|
卷 83, 编号 5 (2011) |
Editorial |
Cardiovascular risk factors in psoriatic and rheumatoid arthritis |
|
卷 83, 编号 5 (2011) |
Editorial |
Arterial stiffness in patients with systemic sclerosis |
|
卷 84, 编号 3 (2012) |
Editorial |
Arterial stiffness in patients with chronic obstructive pulmonary disease |
|
卷 84, 编号 9 (2012) |
Editorial |
Vascular remodeling indicators and their impact on prognosis in patients with chronic heart failure |
|
卷 86, 编号 5 (2014) |
Editorial |
Diagnostic value of the determination of angiogenic factors and cytokine composition parameters in the serum and urine of patients with scleroderma systematica |
|
卷 86, 编号 12 (2014) |
Editorial |
Etoricoxib in the treatment of active sacroiliitis in patients with axial spondyloarthritis, including ankylosing spondylitis |
|
卷 87, 编号 3 (2015) |
Editorial |
Efficiency and safety of different etoricoxib regimens in patients with axial spondyloarthritis, including ankylosing spondylitis |
|
卷 87, 编号 4 (2015) |
Editorial |
HIV/AIDS masks in a therapist’s practice |
|
卷 87, 编号 5 (2015) |
Editorial |
Efficacy and safety of intravenous methylprednisolone in the treatment of patients with active ankylosing spondylitis: Results of a 12-week, prospective, open-label, pilot (METALL) study |
|
卷 89, 编号 5 (2017) |
Editorial |
Changes in the serum concentrations of adhesion molecules and vascular endothelial growth factor in active ankylosing spondylitis patients taking amtolmetin guacil: Results of a 56-week prospective ореn-label controlled observational study |
(Rus)
|
卷 89, 编号 4 (2017) |
Editorial |
Stable high interleukin-17A concentration in patients with ankylosing spondylitis treated with tumor necrosis factor-α inhibitors during a year |
(Rus)
|
卷 89, 编号 12-2 (2017) |
Editorial |
Biomarkers of bone remodeling in ankylosing spondylitis patients using nonsteroidal anti-inflammatory drugs: results of an ETHICS research program |
|
卷 90, 编号 12 (2018) |
Editorial |
Comorbidities in inflammatory joint and spine diseases in XXI century |
(Rus)
|
卷 91, 编号 3 (2019) |
Editorial |
Endothelial dysfunction in patients with chronic obstructive pulmonary disease in combination with coronary heart disease |
(Rus)
|
卷 91, 编号 5 (2019) |
Editorial |
Spondyloarthritis: modern terminology and definitions |
(Rus)
|